A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
- Introduced:
Apr 25, 2017
- Status:
-
Enacted Via Other Measures
Provisions of this bill were incorporated into other bills which were enacted, so there will not likely be further activity on this bill.
Provisions of this bill also appear in:
H.R. 2430: FDA Reauthorization Act of 2017Enacted — Signed by the President on Aug 18, 2017. (compare text) - Prognosis:
-
48% chance of being enacted according to Skopos Labs (details)
History
|
Apr 25, 2017
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
May 10, 2017
|
|
Considered by Senate Committee on Health, Education, Labor, and Pensions
A committee held a hearing or business meeting about the bill.
|
|
May 11, 2017
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
|
Jul 12, 2017
|
|
Related Bill —
Passed House (Senate next)
This activity took place on a related bill, H.R. 2430, possibly in lieu of similar activity on S. 934. |
|
Aug 3, 2017
|
|
Related Bill —
Passed Senate
This activity took place on a related bill, H.R. 2430, possibly in lieu of similar activity on S. 934. |
|
Aug 18, 2017
|
|
Related Bill —
Enacted — Signed by the President
This activity took place on a related bill, H.R. 2430, possibly in lieu of similar activity on S. 934. |
S. 934 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“S. 934 — 115th Congress: FDA Reauthorization Act of 2017.” www.GovTrack.us. 2017. April 23, 2018 <https://www.govtrack.us/congress/bills/115/s934>
- show another citation format:
- APA
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.
Say “Hi” on Messenger
